Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Xtant Medical Holdings Inc (NY: XTNT )

0.5341 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Xtant Medical Holdings Inc

< Previous 1 2 Next >
Xtant Medical Expands Product Portfolio with the Launch of the Cortera(R) Posterior Fixation System
Via ACCESSWIRE
Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Xtant Medical Announces $5.0 Million Private Placement
Via ACCESSWIRE
Xtant Medical to Host Second Quarter 2024 Financial Results Earnings Conference call on August 9, 2024
Via ACCESSWIRE
Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%
Via ACCESSWIRE
Xtant Medical Reports First Quarter 2024 Revenue Growth of 55% and Raises Full Year 2024 Revenue Guidance
Via ACCESSWIRE
Earnings Outlook For Xtant Medical Hldgs
Via Benzinga
Xtant Medical Raises $15M Via Equity Offering
Xtant Medical Holdings, Inc. (AMEX: XTNT) entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a  
Via Benzinga
Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Xtant Medical to Participate in 21st Annual Craig-Hallum Institutional Investor Conference on May 29
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q1 2024
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Via ACCESSWIRE
XTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q4 2023
XTNT stock results show that Xtant Medical Hldgs missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Surgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics Business
Medtech Firm Surgalign Holdings Inc (NASDAQ: SRGA) has entered into an asset purchase agreement to sell its U.S. hardware and biomaterials assets and the equity interests in non-Debtor entities related... 
Via Benzinga
Earnings Scheduled For May 4, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 3, 2022
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. 
Via Benzinga
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday. 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.